Cargando…
Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia
OBJECTIVE: Physiological changes potentially influence disease progression and survival along the Amyotrophic Lateral Sclerosis (ALS)‐Frontotemporal dementia (FTD) spectrum. The peripheral peptides that regulate eating and metabolism may provide diagnostic, metabolic, and progression biomarkers. The...
Autores principales: | Ahmed, Rebekah M., Phan, Katherine, Highton‐Williamson, Elizabeth, Strikwerda‐Brown, Cherie, Caga, Jashelle, Ramsey, Eleanor, Zoing, Margaret, Devenney, Emma, Kim, Woojin S., Hodges, John R., Piguet, Olivier, Halliday, Glenda M., Kiernan, Matthew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414477/ https://www.ncbi.nlm.nih.gov/pubmed/30911572 http://dx.doi.org/10.1002/acn3.721 |
Ejemplares similares
-
Distinct hypothalamic involvement in the amyotrophic lateral sclerosis-frontotemporal dementia spectrum
por: Tse, Nga Yan, et al.
Publicado: (2022) -
Schizotypal traits across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum: pathomechanistic insights
por: Tse, Nga Yan, et al.
Publicado: (2022) -
Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS‐FTD spectrum
por: Devenney, Emma M., et al.
Publicado: (2021) -
Tackling clinical heterogeneity across the amyotrophic lateral sclerosis–frontotemporal dementia spectrum using a transdiagnostic approach
por: Ahmed, Rebekah M, et al.
Publicado: (2021) -
Illness Cognitions in ALS: New Insights Into Clinical Management of Behavioural Symptoms
por: Caga, Jashelle, et al.
Publicado: (2021)